Clinical Trials Logo

Communicable Diseases clinical trials

View clinical trials related to Communicable Diseases.

Filter by:

NCT ID: NCT00424190 Completed - Clinical trials for Bacterial Infections

Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections

cSSSI
Start date: February 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin infections in adults.

NCT ID: NCT00423657 Completed - Clinical trials for Bacterial Infections

Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections

Start date: March 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin infections in adults.

NCT ID: NCT00420966 Completed - Clinical trials for Respiratory Syncytial Virus Infections

Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy

Start date: October 2005
Phase:
Study type: Observational

The purpose of this study is to determine the utilization patterns and compliance rates of palivizumab, which is a monoclonal antibody therapy used to prevent respiratory syncytial virus infection.

NCT ID: NCT00419991 Completed - Clinical trials for Staphylococcal Infections

Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection

Start date: January 2007
Phase: Phase 4
Study type: Interventional

Tigecycline is being developed as an agent that overcomes tetracycline-resistance mechanisms and provides activity against emerging multi-drug resistant pathogens. The purpose of this protocol is to determine the linkage between time related clinical measures of infection response and time to bacterial eradication in patients with intravascular catheter infections caused by Staphylococcus epidermidis and other coagulase negative staphylococci.

NCT ID: NCT00417573 Completed - Infections Clinical Trials

Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections

Start date: December 2004
Phase: Phase 2
Study type: Interventional

- This is the first study, that we are aware of, that will evaluate the efficacy of IgIV in patients with IgG subclass deficiency. - Will provide data for further collaboration in extending study to involve other immunological centers in the United States to study patients with similar disease.

NCT ID: NCT00414518 Completed - HIV Infections Clinical Trials

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

Start date: January 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the safety and effectiveness of an anti-HIV drug regimen followed by treatment interruption in people recently infected with HIV. This study will also compare the effects of a treatment regimen including treatment interruption with a treatment plan based on clinical indicators.

NCT ID: NCT00413738 Completed - Infection Clinical Trials

Prevention of Catheter-Related Bloodstream Infection in Patients With Hemato-Oncological Disease

Start date: December 2006
Phase: Phase 3
Study type: Interventional

The aim of this prospective randomised controlled trial is to compare the incidence of catheter-related bloodstream infection in 2 groups of patients with hemato-oncological disease: Group A: heparin-coated central venous catheters (Control Group) Group B: antiseptic-coated (chlorhexidine-silver sulfadiazine) central venous catheters

NCT ID: NCT00408135 Completed - Infections Clinical Trials

Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections

Start date: August 2004
Phase: Phase 3
Study type: Interventional

The primary objective is to assess the safety of telithromycin (HMR 3647) (20% fine granules) 1g filling sachet in children with infections (Respiratory tract infections, Dermatological infections, Otorhinolaryngological infections, Dentistry/Oral surgery infections). Secondary objectives are to assess the clinical efficacy, bacteriological efficacy and acceptability of telithromycin (20% fine granules) 1g filling sachet in children with infections.

NCT ID: NCT00405509 Completed - Common Cold Clinical Trials

The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years

Start date: October 2006
Phase: N/A
Study type: Observational

This study examines the cold processes of children aged 6 to less than 14. Children will be seen by the study staff 6 days in a row during the course of their naturally-acquired colds. Nasal secretions will be examined for chemicals that the body creates during a cold. Skin cells will be collected by brushing the inside of the child's cheek with a small brush. The cells will be examined for genes that may hold control the creation of these chemicals.

NCT ID: NCT00400322 Completed - Clinical trials for Glioblastoma Multiforme

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Start date: August 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate if treatment of CMV infection by antiviral drug Valcyte (R) affects the clinical outcome of glioblastoma multiforme in patients with local CMV infection in tumor tissue. The investigators' hypothesis states that CMV infection promotes tumor development and disease progression and inhibits immune responses against the tumor.